The cholesterol esterification inhibitor avasimibe suppresses tumour proliferation and metastasis via the E2F-1 signalling pathway in prostate cancer

BACKGROUND: New effective drugs for prostate cancer (PCa) treatment are urgently needed. Avasimibe was recently identified as a promising drug for anticancer therapies. The main purpose of this study was to explore the effects and the underlying mechanisms of avasimibe in prostate cancer. METHODS: I...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Kangping, Wang, Gang, Peng, Tianchen, Zhou, Fenfang, Chen, Siming, Liu, Wei, Ju, Lingao, Xiao, Yu, Qian, Kaiyu, Wang, Xinghuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407011/
https://www.ncbi.nlm.nih.gov/pubmed/34461908
http://dx.doi.org/10.1186/s12935-021-02175-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407011/
https://www.ncbi.nlm.nih.gov/pubmed/34461908
http://dx.doi.org/10.1186/s12935-021-02175-5

Ejemplares similares